Understanding Left Ventricle End-Systolic Dimension (LVESD): Normal vs Optimal Ranges

?What is Left Ventricle End-Systolic Dimension (LVESD)?

Left ventricle end-systolic dimension (LVESD) measures the diameter of the left ventricle at its smallest point during the heart's contraction phase. This measurement is obtained via echocardiography and reflects the chamber's size when it is maximally squeezed. LVESD is a key indicator of left ventricular function and cardiac remodelling.

!Why It Matters

LVESD helps assess cardiac contractility and can indicate whether the heart is enlarging or functioning normally. Elevated LVESD may suggest ventricular dilation, weakened heart function, or cardiomyopathy, while lower values generally reflect better systolic performance. Monitoring this dimension is important for detecting heart disease progression and guiding treatment decisions.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Shortness of breath or dyspnea
• Fatigue and reduced exercise tolerance
• Chest discomfort or palpitations
• Peripheral oedema or swelling in legs and ankles
• Dizziness or lightheadedness

How to Improve Your Levels

• 1Manage blood pressure through dietary sodium reduction and antihypertensive medications if prescribed
• 2Engage in regular, moderate aerobic exercise as approved by your cardiologist
• 3Maintain a heart-healthy diet rich in vegetables, whole grains, and lean proteins
• 4Limit alcohol consumption and avoid smoking
• 5Take prescribed cardiac medications (ACE inhibitors, beta-blockers) consistently
• 6Manage underlying conditions such as diabetes and hyperlipidaemia

When to Test

LVESD is typically measured during echocardiography when evaluating symptoms of heart disease, monitoring known cardiomyopathy, assessing the impact of hypertension, or after myocardial infarction. Repeat measurements may be ordered to track disease progression or response to cardiac medications over time.

Related Biomarkers